ВРТ1. Название Стр
 Скачать 1.93 Mb.
|
|
Performing the embryo transfer: a guideline. Fertil Steril [Internet]. 2017;107(4):882–96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28366416 58. Brown J, Buckingham K, Buckett W, Abou-Setta AM. Ultrasound versus “clinical touch” for catheter guidance during embryo transfer in women. Cochrane database Syst Rev. 2016;3:CD006107. 59. Buckett WM. A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer. Fertil Steril [Internet]. 2006;85(3):728–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16500345 60. Sroga JM, Montville CP, Aubuchon M, Williams DB, Thomas MA. Effect of delayed versus immediate embryo transfer catheter removal on pregnancy outcomes during fresh cycles. Fertil Steril [Internet]. 2010;93(6):2088–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20116786 61. Tiras B, Polat M, Korucuoglu U, Zeyneloglu HB, Yarali H. Impact of embryo replacement depth on in vitro fertilization and embryo transfer outcomes. Fertil Steril [Internet]. 2010;94(4):1341–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20044085 62. Bontekoe S, Heineman MJ, Johnson N, Blake D. Adherence compounds in embryo transfer media for assisted reproductive technologies. Cochrane database Syst Rev. 2014;(2):CD007421. 63. Craciunas L, Tsampras N, Fitzgerald C. Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril [Internet]. 2014;101(5):1302–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24602754 64. Oraif A, Hollet-Caines J, Feyles V, Rebel M, Abduljabar H. Do multiple attempts at embryo transfer affect clinical pregnancy rates? J Obstet Gynaecol Can. 2014;36(5):406–7. 65. Kroon B, Hart RJ, Wong BMS, Ford E, Yazdani A. Antibiotics prior to embryo transfer in ART. Cochrane database Syst Rev [Internet]. 2012;(3):CD008995. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22419341 66. van der Ven H, Diedrich K, Al-Hasani S, Pless V, Krebs D. The effect of general anaesthesia on the success of embryo transfer following human in-vitro fertilization. Hum Reprod [Internet]. 1988;3 Suppl 2:81–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3068244 67. European IVF-monitoring Consortium (EIM), European Society of Human Reproduction and Embryology (ESHRE), Calhaz-Jorge C, De Geyter C, Kupka MS, de Mouzon J, et al. Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Hum Reprod. 2017;32(10):1957–73. 68. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the Society for Assisted Reproductive Technology. Guidance on the limits to the number of embryos to transfer: a committee opinion. Fertil Steril [Internet]. 2017;107(4):901–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28292618 69. Mancuso AC, Boulet SL, Duran E, Munch E, Kissin DM, Van Voorhis BJ. Elective single 149 embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics. Fertil Steril. 2016 Oct;106(5):1107–14. 70. Kissin DM, Kulkarni AD, Mneimneh A, Warner L, Boulet SL, Crawford S, et al. Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention. Fertil Steril [Internet]. 2015;103(4):954–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25637480 71. Richter KS, Ginsburg DK, Shipley SK, Lim J, Tucker MJ, Graham JR, et al. Factors associated with birth outcomes from cryopreserved blastocysts: experience from 4,597 autologous transfers of 7,597 cryopreserved blastocysts. Fertil Steril [Internet]. 2016;106(2):354--362.e2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27172399 72. Chen X, Liu P, Sheng Y, Li W, Tang R, Ding L, et al. The impact of unicornuate uterus on perinatal outcomes after IVF/ICSI cycles: a matched retrospective cohort study. J Matern Fetal Neonatal Med [Internet]. 2018;1–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29649918 73. JOINT SOGC-CFAS. Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006. Int J Gynaecol Obstet. 2008;102(2):203–16. 74. Prevention of twin pregnancies after IVF/ICSI by single embryo transfer. ESHRE Campus Course Report. Hum Reprod [Internet]. 2001;16(4):790–800. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11278236 75. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril [Internet]. 1994;61(6):1068–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8194619 76. Connell MT, Szatkowski JM, Terry N, DeCherney AH, Propst AM, Hill MJ. Timing luteal support in assisted reproductive technology: a systematic review. Fertil Steril [Internet]. 2015;103(4):939--946.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25638420 77. van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane database Syst Rev. 2015;(7):CD009154. 78. Child T, Leonard SA, Evans JS, Lass A. Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles. Reprod Biomed Online [Internet]. 2018;36(6):630–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29550390 79. Shapiro DB, Pappadakis JA, Ellsworth NM, Hait HI, Nagy ZP. Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts. Hum Reprod [Internet]. 2014;29(8):1706–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24847018 80. Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod [Internet]. 2017;32(10):2152. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28938733 81. Применение эстрогенов в программах ВРТ. Научно-практические рекомендации. РАРЧ. 2015. 82. Корсак ВС, Каменецкий БА, Михайлов АВ. Значимость толщины и ультразвуковой структуры эндометрия в программе ЭКО. Проблемы репродукции. 2001;7(3):36–9. 83. Aydin T, Kara M, Nurettin T. Relationship between Endometrial Thickness and In Vitro Fertilization-Intracytoplasmic Sperm Injection Outcome. Int J Fertil Steril [Internet]. 2013;7(1):29–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24520460 84. Al-Ghamdi A, Coskun S, Al-Hassan S, Al-Rejjal R, Awartani K. The correlation between 150 endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome. Reprod Biol Endocrinol [Internet]. 2008;6:37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18764940 85. Xiao Z, Zhou X, Xu W, Yang J, Xie Q. Natural cycle is superior to hormone replacement therapy cycle for vitrificated-preserved frozen-thawed embryo transfer. Syst Biol Reprod Med [Internet]. 2012;58(2):107–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22206474 86. Groenewoud ER, Macklon NS, Cohlen BJ, trial study group A. Cryo-thawed embryo transfer: natural versus artificial cycle. A non-inferiority trial. (ANTARCTICA trial). BMC Womens Health [Internet]. 2012;12:27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22950651 87. Liao X, Li Z, Dong X, Zhang H. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer. Int J Clin Exp Pathol [Internet]. 2014;7(10):6992–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25400786 88. Mao G-H, Feng Z, He Y, Huang Y-R. Comparisons of the effects of long-acting and short- acting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro fertilization. Arch Med Sci [Internet]. 2014;10(1):161–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24701229 89. Jung H, Roh HK. The effects of E2 supplementation from the early proliferative phase to the late secretory phase of the endometrium in hMG-stimulated IVF-ET. J Assist Reprod Genet [Internet]. 2000;17(1):28–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10754780 90. Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril [Internet]. 2004;81(1):1–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14711532 91. Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за 2015г. Проблемы репродукции. 2017;23(5):8–22. 92. Корнеева ЕИ. Федеральные клинические рекомендации. Диагностика и лечение синдрома гиперстимуляции яичников. Москва; 2013. 93. Casper RF. Reducing the Risk of OHSS by GnRH Agonist Triggering. J Clin Endocrinol Metab [Internet]. 2015;100(12):4396–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26513003 94. Leitao VMS, Moroni RM, Seko LMD, Nastri CO, Martins WP. Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials. Fertil Steril [Internet]. 2014;101(3):664–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24360566 95. Sousa M, Cunha M, Teixeira da Silva J, Oliveira C, Silva J, Viana P, et al. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles. Reprod Biol Endocrinol [Internet]. 2015;13:66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26100393 96. Das M, Son W-Y, Buckett W, Tulandi T, Holzer H. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome. Reprod Biomed Online [Internet]. 2014;29(5):545– 51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25262236 97. Refaat B, Dalton E, Ledger WL. Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies. Reprod Biol Endocrinol 151 [Internet]. 2015;13:30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25884617 98. Shaw JL V, Dey SK, Critchley HOD, Horne AW. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update [Internet]. 16(4):432–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20071358 99. Ankum WM, Mol BW, Van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril [Internet]. 1996;65(6):1093–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8641479 100. Audebert A, Pouly JL, Bonifacie B, Yazbeck C. Laparoscopic surgery for distal tubal occlusions: lessons learned from a historical series of 434 cases. Fertil Steril [Internet]. 2014;102(4):1203–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25150389 101. Hjordt Hansen M V, Dalsgaard T, Hartwell D, Skovlund CW, Lidegaard O. Reproductive prognosis in endometriosis. A national cohort study. Acta Obstet Gynecol Scand [Internet]. 2014;93(5):483–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24617701 102. Egbase PE, Al-Sharhan M, Grudzinskas JG. Influence of position and length of uterus on implantation and clinical pregnancy rates in IVF and embryo transfer treatment cycles. Hum Reprod [Internet]. 2000;15(9):1943–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10966991 103. Nazari A, Askari HA, Check JH, O’Shaughnessy A. Embryo transfer technique as a cause of ectopic pregnancy in in vitro fertilization. Fertil Steril [Internet]. 1993;60(5):919–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8224280 104. Pandian Z, Marjoribanks J, Ozturk O, Serour G, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane database Syst Rev. 2013;(7):CD003416. 105. Vloeberghs V, Peeraer K, Pexsters A, D’Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol [Internet]. 2009;23(5):691–709. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19632900 106. Özaltın S, Kumbasar S, Savan K. Evaluation of complications developing during and after transvaginal ultrasound - guided oocyte retrieval. Ginekol Pol [Internet]. 2018;89(1):1–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29411339 107. Bodri D, Guillén JJ, Polo A, Trullenque M, Esteve C, Coll O. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online [Internet]. 2008;17(2):237–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18681998 108. Ludwig AK, Glawatz M, Griesinger G, Diedrich K, Ludwig M. Perioperative and post- operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals. Hum Reprod [Internet]. 2006;21(12):3235–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877373 109. Sarhan A, Muasher SJ. Surgical complications of in vitro fertilization. Review. Middle East Fert Soc J. 2007;12(1):N1. 110. Serour GI, Aboulghar M, Mansour R, Sattar MA, Amin Y, Aboulghar H. Complications of medically assisted conception in 3,500 cycles. Fertil Steril [Internet]. 1998;70(4):638–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9797090 111. Roest J, Mous H V, Zeilmaker GH, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update [Internet]. 2(4):345–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9080231 112. Govaerts I, Devreker F, Delbaere A, Revelard P, Englert Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J 152 Obstet Gynecol Reprod Biol [Internet]. 1998;77(2):239–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9578285 113. Кулаков ВИ, Леонов БВ. Экстракорпоральное оплодотворение и его новые направления в лечении женского и мужского бесплодия (теоретические и практические подходы): Руководство для врачей. МИА. Москва; 2004. 782 p. 114. Mashiach S, Bider D, Moran O, Goldenberg M, Ben-Rafael Z. Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertil Steril [Internet]. 1990;53(1):76–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2295348 115. Romanski PA, Melamed A, Elias KM, Stanic AK, Anchan RM. Association between peak estradiol levels and ovarian torsion among symptomatic patients receiving gonadotropin treatment. J Assist Reprod Genet [Internet]. 2017;34(5):627–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28299550 116. Kemmann E, Ghazi DM, Corsan GH. Adnexal torsion in menotropin-induced pregnancies. Obstet Gynecol [Internet]. 1990;76(3 Pt 1):403–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2116611 117. Bouguizane S, Bibi H, Farhat Y, Dhifallah S, Darraji F, Hidar S, et al. [Adnexal torsion: a report of 135 cases]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2003;32(6):535–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14593299 118. Chang HC, Bhatt S, Dogra VS. Pearls and pitfalls in diagnosis of ovarian torsion. Radiographics [Internet]. 28(5):1355–68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18794312 119. Huchon C, Fauconnier A. Adnexal torsion: a literature review. Eur J Obstet Gynecol Reprod Biol [Internet]. 2010;150(1):8–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20189289 120. Mashiach R, Melamed N, Gilad N, Ben-Shitrit G, Meizner I. Sonographic diagnosis of ovarian torsion: accuracy and predictive factors. J Ultrasound Med [Internet]. 2011;30(9):1205–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21876091 121. Steyaert SR, Leroux-Roels GG, Dhont M. Infections in IVF: review and guidelines. Hum Reprod Update [Internet]. 6(5):432–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11045874 122. Assisted reproductive technology in Europe 2013: results generated from European registers by ESHRE., Calhaz-Jorge C, Christian De Geyter, M S Kupka et al. Revised guidelines for good practice in IVF laboratories (2015). Hum Reprod [Internet]. 2017;32(10):1957–73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26908842 123. Pereira N, Hutchinson AP, Lekovich JP, Hobeika E, Elias RT. Antibiotic Prophylaxis for Gynecologic Procedures prior to and during the Utilization of Assisted Reproductive Technologies: A Systematic Review. J Pathog [Internet]. 2016;2016:4698314. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27047692 124. Arafa M, El Tabie O. Medical treatment of retrograde ejaculation in diabetic patients: a hope for spontaneous pregnancy. J Sex Med [Internet]. 2008;5(1):194–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17433085 125. Ohl DA, Quallich SA, Sønksen J, Brackett NL, Lynne CM. Anejaculation and retrograde ejaculation. Urol Clin North Am [Internet]. 2008;35(2):211--20, viii. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18423241 126. Brackett NL, Ibrahim E, Iremashvili V, Aballa TC, Lynne CM. Treatment for ejaculatory dysfunction in men with spinal cord injury: an 18-year single center experience. J Urol [Internet]. 2010;183(6):2304–8. Available from: 153 http://www.ncbi.nlm.nih.gov/pubmed/20400139 127. Ohl DA, Quallich SA, Sønksen J, Brackett NL, Lynne CM. Anejaculation: an electrifying approach. Semin Reprod Med [Internet]. 2009;27(2):179–85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19247920 128. Brackett NL, Lynne CM, Ibrahim E, Ohl DA, Sønksen J. Treatment of infertility in men with spinal cord injury. Nat Rev Urol [Internet]. 2010;7(3):162–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20157304 129. Корнеев ИА, Зассеев РД. Преодоление бесплодия у мужчин с ретроградной эякуляцией и анэякуляцией. Урологические ведомости. 2017;7(2):10–5. |